Similar articles

• Neuromedical Systems, Inc.

  Mango LJ. Mango LJ. Acta Cytol. 1996 Jan-Feb;40(1):53-9. doi: 10.1159/000333585. Acta Cytol. 1996. PMID: 8604575 Review. No abstract available.
• Improved quality-control detection of false-negative Pap smears using the Autopap 300 QC system.

  Marshall CJ, Rowe L, Bentz JS. Marshall CJ, et al. Diagn Cytopathol. 1999 Mar;20(3):170-4. doi: 10.1002/(sici)1097-0339(199903)20:3<170::aid-dc12>3.0.co;2-6. Diagn Cytopathol. 1999. PMID: 10086244
• The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.

  Patten SF Jr, Lee JS, Wilbur DC, Bonfiglio TA, Colgan TJ, Richart RM, Cramer H, Moinuddin S. Patten SF Jr, et al. Cancer. 1997 Dec 25;81(6):337-42. doi: 10.1002/(sici)1097-0142(19971225)81:6<337::aid-cncr7>3.0.co;2-i. Cancer. 1997. PMID: 9438458 Clinical Trial.
• Determining the utility and effectiveness of the NeoPath AutoPap 300 QC System used routinely.

  Fetterman B, Pawlick G, Koo H, Hartinger J, Gilbert C, Connell S. Fetterman B, et al. Acta Cytol. 1999 Jan-Feb;43(1):13-22. doi: 10.1159/000330862. Acta Cytol. 1999. PMID: 9987444
• Automated rescreening in cervical cytology. Mathematical models for evaluating overall process sensitivity, specificity and cost.

  Kaminsky FC, Benneyan JC, Mullins DL. Kaminsky FC, et al. Acta Cytol. 1997 Jan-Feb;41(1):209-23. doi: 10.1159/000332324. Acta Cytol. 1997. PMID: 9022745 Review.